Thomas Jankowski
Papers
1
Total Citations
9
H-Index
1
About
Thomas Jankowski is a leading urologic oncologist whose research focuses on optimizing functional outcomes and quality of life following robot-assisted radical prostatectomy (RARP) for prostate cancer. His major contributions center on defining and measuring "pentafecta" criteria—the ideal combination of cancer control, urinary continence, erectile function, and complication-free recovery—and linking these outcomes to validated risk stratification tools. In his highly cited 2022 study, Jankowski demonstrated that men achieving pentafecta outcomes after RARP experience clinically meaningful improvements in quality of life, as measured by the EORTC QLQ-C30, even when stratified by CAPRA-S risk scores. This work has been cited 9 times and provides critical evidence for patient counseling and shared decision-making. Jankowski’s research bridges the gap between surgical technique and patient-reported outcomes, offering a nuanced understanding of how optimal surgical results translate into real-world well-being. His findings are instrumental for clinicians seeking to set realistic expectations and for researchers designing future trials on postoperative recovery.
Research Focus
Key Achievements
Top Papers
- 1